Fatty Acid Synthase (FAS) Inhibitors

Fatty acid synthase (FAS) inhibitors are a class of compounds that target the FAS enzyme which plays a crucial role in the synthesis of fatty acids As its name suggests FAS inhibitors are designed to inhibit the activity of this enzyme thus impeding the production of fatty acids This is especially relevant in the context of diseases such as cancer as cancer cells typically have high levels of FAS activity to support their rapid growth By blocking FAS FAS inhibitors offer a potential therapeutic strategy for inhibiting tumor growth and progression Our company specializes in providing a range of advanced FAS inhibitors offering researchers and clinicians valuable tools for studying and potentially treating FAS-dependent diseases

Catalog Number	Chemical Name	CAS #	Price
BC-0835	Cerulenin	17397-89-6	Online Inquiry
EI-0767	DPVP	223386-36-5	Online Inquiry
EI-0968	FAS Inhibitor, C75	191282-48-1	Online Inquiry
EI-1097	GSK-2194069	1332331-21-1	Online Inquiry
EI-1291	KR-33493	1021497-97-1	Online Inquiry
EI-2224	TVB-2640	1399177-37-7	Online Inquiry
EI-2359	α-Mangostin	6147-11-1	Online Inquiry

Application

Fatty Acid Synthase (FAS) Inhibitors offer numerous applications in the field of cancer research and treatment By targeting the activity of FAS these inhibitors can effectively disrupt the synthesis of fatty acids which are essential for the growth and proliferation of cancer cells Inhibiting FAS can halt cancer cell growth and potentially lead to the development of novel anti-cancer therapies

Furthermore FAS inhibitors can also be utilized in metabolic research to explore the role of fatty acid synthesis in various biological processes By modulating FAS activity scientists can gain a deeper understanding of how fatty acids contribute to cellular functions metabolic disorders and other diseases

In the pharmaceutical industry FAS inhibitors hold promise for the development of anti-obesity drugs By inhibiting the synthesis of fatty acids these inhibitors can help regulate lipid metabolism and potentially reduce the accumulation of fat in the body Such drugs could be valuable tools for combating obesity and related health conditions

Overall Fatty Acid Synthase (FAS) Inhibitors offer a wide range of applications in cancer research metabolic studies and the development of novel therapeutics for cancer metabolic disorders and obesity

Please note that all services are for research use only. Not intended for any clinical use.

Fatty Acid Synthase (FAS) Inhibitors